TerrAscend Corp.

The CIN framework assigns TerrAscend a Neutral rating at 57/100, with conviction of 2 out of 5. Four pillars feed the composite in fixed weights (35/25/25/15 for fundamentals, regulatory, market, and editorial), and no clause of the score is hidden from the reader. Fundamentals carries this profile, printing 72 and setting the ceiling on the composite. The editorial pillar sits at 30, and is the main drag on the composite.

Under the hood, the data points sit as follows: reported revenue growth of 1.9 percent year over year, an operating margin of 17.6 percent, a market cap near 212 million, a filing cadence of 3 regulator events in the trailing 90 days, a jurisdictional posture reading of 80. Each of those figures ties back to a specific input in the pillar breakdown. The scoring pipeline pulls only from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage, and each pillar exposes its own inputs. This lets TerrAscend be lined up against the global cannabis coverage universe on identical inputs, with refresh cadence tied directly to primary-source ingest.

The next quarterly release stands as the primary catalyst, since fundamentals drive 72 of the composite. A revenue print above the trailing four-quarter average combined with a stable operating margin would justify a step toward the upper band edge, while a miss on either would erode the Neutral anchor.